PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study | PHASE SCIENTIFIC

PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study, Marking New Era of Non-Invasive Cervical Cancer Screening Guang’an, Sichuan, September 20, 2025 – PHASE Scientific International Limited (“PHASE Scientific”) today announced the official launch of the world’s largest clinical study for urine-based cervical cancer (HPV) screening, with the first site established in Guang’an, Sichuan Province, China. This study is led by Peking University Shenzhen Hospital, with participation from West China Guang’an Hospital of Sichuan University and technical and diagnostic support by PHASE Scientific. The study applies PHASE Scientific’s proprietary PHASiFY™ urine-based DNA concentration technology, aiming to explore a scalable, accessible approach to cervical cancer prevention that delivers next-level public health impact with scientific innovation. This prospective study plans to include 17,000 eligible women, evaluating the clinical performance of

PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study | PHASE SCIENTIFIC Skip to main content ENG ENG 繁體 简体 Share to Facebook Twitter LinkedIn Weibo WhatsApp WeChat Email Close Careers Media Centre Americas China Contact Us Hong Kong China Americas Home PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study Press Release September 22, 2025 PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study, Marking New Era of Non-Invasive Cervical Cancer

related reading

• Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer - PMCncbi.nlm.nih.gov
• Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer - PubMedpubmed.ncbi.nlm.nih.gov
• B.C. physicians’ Pap-a-palooza like a ‘golden ticket’ for patients - Healthy Debatehealthydebate.ca
• HPV vaccine cutting cervical cancer by nearly 90%bbc.com
• Announcing Preventive — Preventivepreventive.bio
• About Us | Papcup - Biosensor Technology Teampapcup.co.uk
• Orchid | Whole Genome Embryo Screening for IVForchidhealth.com
• Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapyfrontiersin.org
• Nasopharyngeal Carcinoma(Archived) - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis | Journal of Biomedical Science | Springer Nature Linkjbiomedsci.biomedcentral.com
• This "amateur" programmer fought cancer with 50 Nvidia Geforce 1080Tihowardchen.substack.com
• HPV and Cancer - NCIcancer.gov